Ulcerative colitis: open trials in Chile

• NCT07652294

  Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD

  Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

  Osorno · Santiago

  Registry updated 2026-11-03

• NCT06619990

  Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

  Trial Treatment · Phase 1/2 · Xencor, Inc.

  Santiago

  Registry updated 2026-10-30

• NCT07012395

  A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

  Trial Treatment · Phase 2 · Spyre Therapeutics, Inc.

  Osorno · Santiago

  Registry updated 2026-10-27

• NCT07185009

  A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

  Trial Treatment · Phase 3 · Sanofi

  Santiago · Santiago · Viña del Mar

  Registry updated 2026-10-16

• NCT07752446

  Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis Remission

  Trial Treatment · Pontificia Universidad Catolica de Chile

  Pontificia Universidad Catolica de Chile, Santiago

  Registry updated 2026-08-07

• NCT06758024

  PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

  Trial Treatment · Pontificia Universidad Catolica de Chile

  Pontificia Universidad Catolica of Chile, Santiago

  Registry updated 2025-02-28

• NCT06756100

  Early Inflammatory Bowel Disease Progression

  Research · Pontificia Universidad Catolica de Chile

  Pontificia Universidad Catolica of Chile, Santiago

  Registry updated 2025-01-01

All Ulcerative colitis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error